|
Determinants of cancer incidence and mortality among people with vitamin D deficiency: an epidemiology study using a real-world population database
|
06 October 2025 |
|
Incidence of gynecological cancers following prolactin-increasing antipsychotic use: a population cohort study
|
03 October 2025 |
|
Prolactin secreting pituitary neuroendocrine tumors treated by dopamine agonists: predictors of response
|
03 October 2025 |
|
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study
|
25 September 2025 |
|
Causal analysis of the impact of serum 25-hydroxyvitamin D levels on laryngeal cancer: A two-sample mendelian randomization study
|
19 September 2025 |
|
Vitamin D3 reduces the viability of cancer cells in vitro and retard the EAC tumors growth in mice
|
12 September 2025 |
|
Targeting the self-amplifying loop between ATF6 and SNAI1 to inhibit epithelial‒mesenchymal transition in fibrotic lesions
|
12 September 2025 |
|
Melatonin-induced ferroptosis in pancreatic cancer cells by stimulating endoplasmic reticulum stress and inhibiting alanine-serine-cysteine transporter 2-driven glutamine metabolism
|
10 September 2025 |
|
Efficacy of Melatonin in Alleviating Radiotherapy-Induced Fatigue, Anxiety, and Depression in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
|
05 September 2025 |
|
The Role of Dopamine in Neurological, Psychiatric, and Metabolic Disorders and Cancer: A Complex Web of Interactions
|
05 September 2025 |
News-Papers
Testimonial
Video Gallery 
